Navigation Links
Applied Computational Technologies Appoints a New CEO
Date:6/16/2008

Kathy Blum Will Help Drive the Commercialization of Company's Cancer

Therapy Product

PITTSBURGH, June 16 /PRNewswire/ -- Applied Computational Technologies (AppCompTech) has announced the appointment of Kathy Blum as the company's new Chief Executive Officer. With extensive experience in leading medical device, service and IT related businesses as well as global experience with start-ups and Fortune 500 organizations, Ms. Blum brings 27 years of industry knowledge and leadership with her as the new CEO of Applied Computational Technologies.

As CEO, Ms. Blum will be driving AppCompTech's mission to provide advanced radiation oncology treatment planning with ProACTive(TM) -- the company's groundbreaking software technology that is a dose calculation module which provides increased accuracy and greater speed in planning targeted radiation treatment.

"Ms. Blum will play a critical role in raising our final round of investment funding and positioning Applied Computational Technologies in the radiation therapy systems market," said Jay McClatchey, AppCompTech Co-founder. "Our software blends incredible speed with accuracy, enabling adaptive planning for a significant competitive advantage over existing treatment technology. We are all looking forward to working together to complete testing and bring our product ProACTive to market."

"In 2008 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy," said Ms. Blum. "I am honored to be part of an organization that is developing a product that can make radiation therapy more efficient and effective and help save more lives."

In addition, AppCompTech has formed an important strategic partnership with D3 Radiation Planning, a UPMC affiliated radiation oncology service company that offers advanced radiation treatment planning to hospitals and freestanding institutions. D3 will play a critical role in the testing and clinical evaluation of ProACTive. Hospitals and freestanding institutions currently utilize D3 to provide their patients with advanced radiation therapy planning for Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT). D3 has performed tens of thousands of treatment plans for over 75 customers worldwide.

About Applied Computational Technologies

Applied Computational Technologies is a software development company focused on a life sciences application in Radiation Treatment Planning for Cancer Therapy. Applied Computational Technologies' patented technology/software, called ProACTive(TM), shatters today's industry-wide speed barrier to high accuracy dose calculation for radiation therapy. The company blends incredible speed with accuracy, enabling adaptive planning for a significant competitive advantage over existing treatment technology. http://www.appcomptech.com


'/>"/>
SOURCE Applied Computational Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
2. Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development
3. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
4. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
5. Study Examines Media Preferences of Life Scientists in Applied Markets
6. Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
7. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
8. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
9. Senesco Technologies to Present at BIO 2008 Business Forum
10. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
11. Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... control cells — optogenetics — is key to exciting advances in the study ... spatially patterned light projected via free-space optics stimulates small, transparent organisms and excites ...
(Date:12/8/2016)... Mass (PRWEB) , ... December 08, 2016 , ... ... genetic data bioInformatics portal. In response to client demand KbioBox developed a sophisticated ... edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... 2016   Biocept, Inc . (NASDAQ: ... clinically actionable liquid biopsy tests to improve the ... featuring its Target Selector™ Circulating Tumor Cell platform ... detection of actionable biomarkers in patients with metastatic ... Sara Cannon Research Institute (SCRI), the research arm ...
Breaking Biology Technology:
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
(Date:11/29/2016)... 2016 BioDirection, a privately held medical device ... objective detection of concussion and other traumatic brain injury ... a meeting with the U.S. Food and Drug Administration ... Package. During the meeting company representatives reviewed plans for ... to commencement of a planned pilot trial. ...
(Date:11/22/2016)... 22, 2016 According to the new market research ... Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and ... the market is expected to grow from USD 10.74 Billion in 2015 ... between 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):